Market closed

ATAI Life Sciences/$ATAI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About ATAI Life Sciences

ATAI Life Sciences NV is a clinical-stage biopharmaceutical company on a mission to develop effective mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 (buccal film DMT) for treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder. It is also advancing a drug discovery program to identify novel, non-hallucinogenic 5-HT2AR agonists for TRD.

Ticker

$ATAI
Trading on

Industry

Pharmaceuticals
Headquarters

Employees

54
Website

ATAI Metrics

BasicAdvanced
$292M
-
-$0.93
1.19
-
$292M
1.19
$2.57
$1.03
1.7M
3.211
2.552
12.754
21.197
-31.94%
-27.54%
-83.16%
764.431
2.12
2.19
-2.853
-1.91%
268.02%
-75.28%
-8.43%

What the Analysts think about ATAI

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for ATAI Life Sciences stock.

ATAI Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

ATAI Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $ATAI

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs

What’s the current market cap for ATAI Life Sciences stock?

ATAI Life Sciences (ATAI) has a market cap of $292M as of April 20, 2025.

What is the P/E ratio for ATAI Life Sciences stock?

The price to earnings (P/E) ratio for ATAI Life Sciences (ATAI) stock is 0 as of April 20, 2025.

Does ATAI Life Sciences stock pay dividends?

No, ATAI Life Sciences (ATAI) stock does not pay dividends to its shareholders as of April 20, 2025.

When is the next ATAI Life Sciences dividend payment date?

ATAI Life Sciences (ATAI) stock does not pay dividends to its shareholders.

What is the beta indicator for ATAI Life Sciences?

ATAI Life Sciences (ATAI) has a beta rating of 1.19. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.